• Je něco špatně v tomto záznamu ?

TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballism

E. Kafantari, VJ. Hernandez, J. Necpál, M. Leonidou, R. Baureder, C. Hedberg-Oldfors, R. Jech, M. Zech, TU. Schwartz, A. Puschmann

. 2025 ; 134 (-) : 107781. [pub] 20250311

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015918

Dystonia is a movement disorder characterized by genetic and clinical heterogeneity. A recurring p.(Glu303del)-deletion in TOR1A is a well-established cause for DYT-TOR1A (DYT1), an autosomal dominant early-onset isolated dystonia. TOR1A encodes TorsinA, an AAA + ATPase located in the nuclear envelope. By whole exome analyses of a family with a novel dystonia-hemichorea-/hemiballism phenotype, we identified a TOR1AIP2 NM_001199260.2 c.1234A > G p.(Arg412Gly) variant. The variant is very rare in databases and was absent from whole exome data from >1000 dystonia patients. TOR1AIP2 encodes LULL1, a transmembrane protein that activates TorsinA, and correct interaction between TorsinA and LULL1 is essential for proper nuclear envelope architecture. The p.(Arg412Gly) variant disrupts the binding interface between TorsinA and LULL1 around p.Arg412; this same interface is also impaired in DYT1. Functional analyses via a co-purification assay revealed that interaction between TorsinA-LULL1Arg412Gly is weaker than the wild-type interaction, and that it resembles the situation in DYT1 (TorsinAΔE303-LULL1). A second family with milder dystonia, hemichorea, and stereotypic leg flexion during gait and a TOR1AIP2 p.(Gln338His) variant was identified. The clinical phenotype of both families shared proximal arm movements, and flutter in facial musculature. Expressivity of the movement disorder symptoms was variable. Several proteins in the nuclear envelope have been implicated in various forms of neurodevelopmental disorders with dystonia. Taken together, our findings suggest TOR1AIP2 as a new candidate gene implicated in a complex hereditary movement disorder with dystonia and hemichorea/hemiballism.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015918
003      
CZ-PrNML
005      
20250731091345.0
007      
ta
008      
250708e20250311enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.parkreldis.2025.107781 $2 doi
035    __
$a (PubMed)40088780
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kafantari, Efthymia $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden. Electronic address: Efthymia.Kafantari@med.lu.se
245    10
$a TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballism / $c E. Kafantari, VJ. Hernandez, J. Necpál, M. Leonidou, R. Baureder, C. Hedberg-Oldfors, R. Jech, M. Zech, TU. Schwartz, A. Puschmann
520    9_
$a Dystonia is a movement disorder characterized by genetic and clinical heterogeneity. A recurring p.(Glu303del)-deletion in TOR1A is a well-established cause for DYT-TOR1A (DYT1), an autosomal dominant early-onset isolated dystonia. TOR1A encodes TorsinA, an AAA + ATPase located in the nuclear envelope. By whole exome analyses of a family with a novel dystonia-hemichorea-/hemiballism phenotype, we identified a TOR1AIP2 NM_001199260.2 c.1234A > G p.(Arg412Gly) variant. The variant is very rare in databases and was absent from whole exome data from >1000 dystonia patients. TOR1AIP2 encodes LULL1, a transmembrane protein that activates TorsinA, and correct interaction between TorsinA and LULL1 is essential for proper nuclear envelope architecture. The p.(Arg412Gly) variant disrupts the binding interface between TorsinA and LULL1 around p.Arg412; this same interface is also impaired in DYT1. Functional analyses via a co-purification assay revealed that interaction between TorsinA-LULL1Arg412Gly is weaker than the wild-type interaction, and that it resembles the situation in DYT1 (TorsinAΔE303-LULL1). A second family with milder dystonia, hemichorea, and stereotypic leg flexion during gait and a TOR1AIP2 p.(Gln338His) variant was identified. The clinical phenotype of both families shared proximal arm movements, and flutter in facial musculature. Expressivity of the movement disorder symptoms was variable. Several proteins in the nuclear envelope have been implicated in various forms of neurodevelopmental disorders with dystonia. Taken together, our findings suggest TOR1AIP2 as a new candidate gene implicated in a complex hereditary movement disorder with dystonia and hemichorea/hemiballism.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a molekulární chaperony $x genetika $7 D018832
650    12
$a chorea $x genetika $7 D002819
650    _2
$a dospělí $7 D000328
650    _2
$a rodokmen $7 D010375
650    12
$a dystonické poruchy $x genetika $7 D020821
650    12
$a dystonie $x genetika $7 D004421
650    _2
$a lidé středního věku $7 D008875
650    12
$a dyskineze $x genetika $7 D020820
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hernandez, Victoria J $u Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
700    1_
$a Necpál, Ján $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia; Department of Neurology, Zvolen Hospital, Zvolen, Slovakia
700    1_
$a Leonidou, Marina $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden
700    1_
$a Baureder, Regina $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Clinical Neurophysiology, Lund, Sweden
700    1_
$a Hedberg-Oldfors, Carola $u Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
700    1_
$a Jech, Robert $u Department of Neurology, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, 121 08, Prague, Czech Republic
700    1_
$a Zech, Michael $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany; Institute of Advanced Study, Technical University of Munich, Garching, Germany
700    1_
$a Schwartz, Thomas U $u Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
700    1_
$a Puschmann, Andreas $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden; SciLifeLab National Research Infrastructure, Sweden
773    0_
$w MED00006198 $t Parkinsonism & related disorders $x 1873-5126 $g Roč. 134 (20250311), s. 107781
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40088780 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091340 $b ABA008
999    __
$a ok $b bmc $g 2366631 $s 1253043
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 134 $c - $d 107781 $e 20250311 $i 1873-5126 $m Parkinsonism & related disorders $n Parkinsonism Relat Disord $x MED00006198
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...